ENVB
ENVB

Enveric Biosciences Inc

NASDAQ · Pharmaceuticals
$2.37
-0.26 (-9.89%)
Analyst Consensus
Strong Buy
7 analysts
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +318.1% upside
Low Target $5.56
Average Target $9.91
High Target $13.09
Current Price $2.37
Current
$2.37
Target
$9.91
$5.56 $9.91 avg $13.09